• SmartestCrowd
    • No organizations
    • No projects
0
0
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM - nejm.org
6/4/23 at 7:00pm
Organization
nejm.org
Author
nejm.org
12 words
0
Comments
You are the first to view
https://www.nejm.org/doi/full/10.1056/NEJMoa2304594
Create an account or login to join the discussion